Page 55 - Pharmaceutical Solution for Pharma Analysis
P. 55

Application  No.M272
    News
            The results (chromatograms) of analyzing active    Though its peak strength is smaller than that observed
            pharmaceutical ingredients in the detector splitting   in the standard solution, a peak was also detected at
            system are shown in Fig. 6, and the mass spectra of   the elution position of o-xylene (c). Checking the mass
            detected peaks are shown in Fig. 7 to 9. Peaks a and b,   spectrum of this peak (Fig. 9) showed it differed from
            based on their respective mass spectra (Fig. 7 and 8),   the mass spectrum of xylene (peak d, Fig. 10), and was
            were estimated to be ethyl acetate and butanol. Both   estimated to be dibutyl ether.
            these constituents are low toxicity class 3 solvents.

                                                                                      Class1 Standard
                                                                                           (FID)





                                 5.0       10.0      15.0      20.0       25.0    d  30.0      35.0
                                                                                     Class2A Standard
                                                                                           (FID)



                                 5.0       10.0      15.0      20.0       25.0      30.0      35.0
                                                                                     Class2B Standard
                                                                                           (FID)




                                 5.0       10.0      15.0      20.0       25.0      30.0  Test (FID)  35.0
                                                                                c
                                                    b
                                       a

                                 5.0       10.0      15.0      20.0       25.0      30.0  Test (MS)  35.0






                                      Fig. 6  Chromatograms of Standard Solutions and Test Solutions
             100  43.0                         Ethyl acetate    100   57.0                         Dibutylether

              50  29.0                                           50
                    61.0                                            41.0    87.1
              0          88.1                                    0       73.1      130.2
                   50      100      150      200      250             50      100      150      200      250
                        Fig. 7  Mass Spectrum of Peak a                    Fig. 9  Mass Spectrum of Peak c
             100   56.0                                         100          91.1
                31.0                             n-Butanol                                           o-Xylene
                                                                               106.2
             50                                                 50
                                                                     51.0  77.0
              0                                                  0
                  50       100      150      200      250             50      100      150      200      250
                        Fig. 8  Mass Spectrum of Peak b                   Fig. 10  Mass Spectrum of Peak d
            n Conclusion
            An FID and MS detector splitting system obtains FID and MS data simultaneously in a single analysis, and can be used
            as a simpler method of confirming constituent identity. This system shows promise for use in residual solvent testing of
            pharmaceuticals.
            Note: Reference USP <467>
            This data was obtained by a method that does not conform to the pharmacopoeia, as analytical conditions based on USP <467> was modified before use.
                                                                                                      First Edition: Jul. 2016
                                             For Research Use Only. Not for use in diagnostic procedure.
                                             This publication may contain references to products that are not available in your country. Please contact us to check the availability of these
                                             products in your country.

                                             The content of this publication shall not be reproduced, altered or sold for any commercial purpose without the written approval of Shimadzu.
                                             Company names, product/service names and logos used in this publication are trademarks and trade names of Shimadzu Corporation or its
                                             affiliates, whether or not they are used with trademark symbol “TM” or “®”. Third-party trademarks and trade names may be used in this
                                             publication to refer to either the entities or their products/services. Shimadzu disclaims any proprietary interest in trademarks and trade names
     www.shimadzu.com/an/                    other than its own.
                                             The information contained herein is provided to you "as is" without warranty of any kind including without limitation warranties as to its
                                             accuracy or completeness. Shimadzu does not assume any responsibility or liability for any damage, whether direct or indirect, relating to the
                                             use of this publication. This publication is based upon the information available to Shimadzu on or before the date of publication, and subject
                                             to change without notice.
                                                                                                © Shimadzu Corporation, 2016
   50   51   52   53   54   55   56   57   58   59   60